These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4061537)

  • 1. Acute abdominal condition caused by retrograde bleeding in a postmenopausal patient on estrogen-progestogen therapy.
    Rabinovici J; Frenkel Y; Goldwasser B; Menczer J; Serr DM
    Am J Obstet Gynecol; 1985 Nov; 153(6):677-8. PubMed ID: 4061537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
    Mattsson LA; Samsioe G
    Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen.
    Fink BJ
    Maturitas; 1984 Apr; 5(4):277-80. PubMed ID: 6738374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
    Staland B
    Acta Obstet Gynecol Scand Suppl; 1985; 130():29-35. PubMed ID: 3859973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kliogest--the possibility of hormonal substitution in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1993; 32(3):64-6. PubMed ID: 8037328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints.
    Mattsson LA; Cullberg G; Samsioe G
    Maturitas; 1982 Aug; 4(2):95-102. PubMed ID: 7121296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms.
    Høvik P; Sundsbak HP; Gaasemyr M; Sandvik L
    Maturitas; 1989 Mar; 11(1):75-82. PubMed ID: 2498620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulated knowledge of Kliogest safety aspects.
    Ulrich LG
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():99-102; discussion 102-3. PubMed ID: 8624352
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy.
    Sporrong T; Samsioe G; Larsen S; Mattsson LA
    Maturitas; 1989 Sep; 11(3):209-15. PubMed ID: 2593864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
    Hillard TC; Siddle NC; Whitehead MI; Fraser DI; Pryse-Davies J
    Am J Obstet Gynecol; 1992 Jul; 167(1):1-7. PubMed ID: 1442905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
    Dören M; Reuther G; Minne HW; Schneider HP
    Am J Obstet Gynecol; 1995 Nov; 173(5):1446-51. PubMed ID: 7503183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
    Leather AT; Savvas M; Studd JW
    Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial responses to transdermal estradiol in postmenopausal women.
    Whitehead MI; Padwick ML; Endacott J; Pryse-Davies J
    Am J Obstet Gynecol; 1985 Aug; 152(8):1079-84. PubMed ID: 4025456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the bleeding patterns of postmenopausal women treated with Estrapak-50.
    al-Azzawi F; Hawley J; Parsons A; Hart DM
    Maturitas; 1994 Feb; 18(2):115-25. PubMed ID: 8177092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.